|
|
|
 |
|
 |
 |
|
|
|
| Trade name |
|
|
|
MEDRx Co., Ltd |
| Establishment |
|
|
|
January, 2002 |
| Head office |
|
|
|
431-7 Nishiyama Higashikagawa-city, Kagawa, Japan 769-2712
TEL: +81-879-23-3071
FAX: +81-879-23-3072
|
| Tokyo office |
|
|
|
Shimazuru Build. 2F, 2-35-7 Hama-cho, Nihonbashi, Chuou-ku, Tokyo, Japan 103-0007
TEL：+81-3-3664-9630
FAX：+81-3-3664-9660
|
| Osaka office |
|
|
|
Nishikawa-Mitsui Build. #403, 1-3-14 Kitahama, Chuo-ku, Osaka-city, Osaka, Japan 541-0041
TEL：+81-6-6208-2412
FAX：+81-6-6208-2413
|
| Shirotori Labo |
|
|
|
1055 Matsubara Higashikagawa-city, Kagawa, JAPAN 769-2702
TEL：+81-879-26-3094
FAX：+81-879-26-0036
|
| IL Pharma Inc. |
|
|
|
One Broadway, 14th Floor
Cambridge, MA USA 02142
TEL: +1-617-475-1546
|
| President & CEO |
|
|
|
Masayoshi Matsumura |
| Capital Fund |
|
|
|
2,134 million yen |
| Main business operation |
|
|
|
Pharmaceutical Drug Development based on the transdermal absorption system |
|
|
 |
|
 |
|
|
|
|
|
|
|
|
| January, 2002 |
|
|
|
Founded as MEDRx Co., Ltd |
| April, 2005 |
|
|
|
Became Marketing Authorization Holders for Class I & II pharmaceutical products |
| August, 2005 |
|
|
|
Launch a sales of Iodocoat (R) Ointment 0.9% |
| August, 2007 |
|
|
|
Moving of head office |
| October, 2007 |
|
|
|
Established IL Pharma Inc in USA as a subsidiary |
| September, 2009 |
|
|
|
Established a new joint venture company with Kaneka Co. |
| May, 2010 |
|
|
|
Launch a sales of Amlodipine Oral Jelly used as an anti-hypertensive and in the treatment of angina |
| March, 2011 |
|
|
|
Conclusion of License Agreement for Topical Patch containing etodolac in the U.S. with Kowa Company Ltd. |
| March, 2011 |
|
|
|
Signed License Agreement of the Transdermal Formulation containing NF-κB Decoy Oligonucleotide with AnGes MG Inc. |
|
|
|
|
|
|
|
|
|
|
|
|
Masayoshi Matsumura
President and CEO, MEDRx |
|
|
|
Masayoshi Matsumura graduated from Kyoto Pharmaceutical University and joined the pharmaceutical company, Teikoku Seiyaku Co., Ltd in 1972. He had managed the company as a board member since 1973 and as COO since 1975 until 2000.
He was responsible for research and development of the first generation transdermal poultice (cold and hot hydrophilic patch) and the second generation transdermal poultice (hydrophilic patch including NSAIDs) for the ethical pharmaceutical market. He also took the initiative in forming alliances with pharmaceutical companies involving sales, expansion of business overseas and development of new business. And Teikoku Seiyaku group grew up to current annual sales of 40 billion yen from annual sales of less than 200 million yen in 1972.
He used to be a vice president, Teikoku Seiyaku Co., Ltd, president and CEO, Oｈta Seiyaku Co., Ltd, president and CEO, Teikoku Medix Co., Ltd, president and CEO, Teikoku Kanpo Seiyaku Co., Ltd.
2002- Established MEDRx and became president and CEO, MEDRx Co., Ltd
|
|
Keiko Yamasaki
Board Member, MEDRx
|
|
|
|
She graduated from Faculty of Agriculture in Kagawa University and joined the pharmaceutical company, Teikoku Seiyaku Co., Ltd in 1981. She worked at R&D department and used to be a board member of Teikoku Pharmacare Co., Ltd. She joined MEDRx Co., Ltd in 2002.
2002- Board Member, MEDRx Co., Ltd
|
|
Hiroshi Akitomo
Board Member, MEDRx
|
|
|
|
Hiroshi Akitomo received Master of Agriculture at Kagawa University. He joined the pharmaceutical company, Teikoku Seiyaku Co., Ltd in 1987 and worked at R & D department. He joined MEDRx. Co., Ltd in 2002.
2005- Board Member, MEDRx Co., Ltd
|
|
Yonehiro Matsumura
Board Member, MEDRx
|
|
|
|
Yonehiro Matsumura received Master of Agriculture at Tokyo University and joined as a business consultant in Corporate Directions, Inc in 1995. He joined MEDRx Co., Ltd in 2003 as a board member.
2003- Board Member, MEDRx Co., Ltd
|
|
Jun-ichi Tamura
Board Member, MEDRx
|
|
|
|
Jun-ichi Tamura received Master of Pharmacy at Tohoku Pharmaceutical University. He joined the pharmaceutical company, Dainippon Pharma Co., Ltd in 1968 and used to be the position of operating officer. He joined MEDRx. Co., Ltd in 2005.
2007- Board Member, MEDRx Co., Ltd
|
|
Yuji Kuwabara
Board member, MEDRx
CEO, IL Pharma Inc.
|
|
|
|
Yuji Kuwabara graduated from Faculty of Science in Saitama University. He has had experiences of the clinical research development in TORAY Industries, PAREXEL International and Anges MG since 1981. He joined MEDRx. Co., Ltd in 2005.
2007- CEO, IL Pharma Inc.
2011- Board Member, MEDRx Co., Ltd
|
|
Hidetoshi Hamamoto
Board Member, MEDRx
|
|
|
|
Hidetoshi Hamamoto received Master of Engineering in Tokushima University and joined the pharmaceutical company Teikoku Seiyaku Co., Ltd in 1994. He worked at R&D department. He joined MEDRx. Co., Ltd in 2002.
2005- Manager, R&D department
2011- Board Member, MEDRx Co., Ltd
|
|
|
|
|
|
|
